Table 1. Stemness phenotype of S100A4 WT and mutants compared in the figures.
Assay | WT | NM | CM | CD |
---|---|---|---|---|
OECM1 sphere formation | ++++ | +++ | + | ++ |
FaDu sphere formation | +++ | ++ | ± | + |
memGRP78-OECM1f | +++ | ++++ | ++ | + |
memGRP78-FaDuf | ++++ | ++ | − | +++ |
GRP78 proteinW | +++ | ± | ± | − |
Glut3 proteinW | +++ | + | + | + |
Mice tumor volume | +++ | − | + | ++ |
CK18 (undifferentiation)IHC | +++ | + | − | ++ |
NanogIHC | ++++ | ++ | +++ | + |
p-p53 ser15 (anti-apoptosis)W | +++ | +++ | − | − |
NanogW | ++ | ± | − | − |
Nanog reporter | +++ | + | ++ | + |
Total | 38 | 18 | 4 | 9 |
Positive and negative determine as high and low expression levels in comparison with the GFP, respectively.
flow cytometry
immunoblotting assay
immunochemistry